~~<i id='954AF92891'><strike id='954AF92891'><tt id='954AF92891'><pre id='954AF92891'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

fashion

author：fashion 2025-09-06 01:41:21 - browse：6

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

A couple billion here, a couple billion there, and pretty soon Eli Lilly hopes it will be talking about real money.

Eli Lilly agreed to purchase Point Biopharma Tuesday morning for $1.4 billion, a 90% premium, adding to its pipeline of cancer drugs. Point is developing cancer drugs that deliver a focused dose of radiation to tumor cells. Data for its lead medicine, for prostate cancer, are expected in the fourth quarter. It is also developing a drug for neuroendocrine tumors.

Point operates a 180,000-square-foot radiopharmaceutical manufacturing facility in Indianapolis, and a radiopharmaceutical research and development center in Toronto.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Listen: Biogen's messy board & Laronde's data problem

hotspot

focus

knowledge

entertainment

Wikipedia

explore

AhumaneightcellembryoforIVFselection.K.HardyviaWellcomeCollectionTheannouncementthatSupremeCourtJust

WSS

Make 'food is medicine' a key part of White House nutrition meeting

Readout Newsletter: Beam, Prozac, "TechBio" and more

Virtual repurposing can help discover new uses for existing drugs

Elisabeth Bik tackles the widespread issue of research misconduct

7 people shot in DC, police say

7 people shot in DC, police say

leisure time

fashion

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

Children’s Hospital revives plan for pedestrian bridge

Jerome Adams on the need for new antivirals for Covid

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Medicare proposal to cover medical devices draws a mixed reaction

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

What does generative AI mean for health care? We asked experts

PhRMA sues HHS over Medicare drug price negotiation

State Dept. review finds Biden bears some blame for Afghanistan failures

Inside the fall of star MIT scientist David Sabatini

focus

Cholera vaccine supplies dangerously low, outbreaks surging

Inside the fall of star MIT scientist David Sabatini

Cholera vaccine supplies dangerously low, outbreaks surging

Doctor appointment wait times are getting worse

NEJM study measures Covid brain fog, impact on IQ

Did the public have the right to know Arthur Ashe had AIDS?

knowledge

entertainment

Wikipedia

explore